Skip to main content
. 2017 Oct 19;8(59):100640–100647. doi: 10.18632/oncotarget.22062

Table 2. Summary of the data extraction for meta-analysis.

Author’s Name Year Country HITHOC Non-HITHOC Reference
Total # MST (m) RFI (m) Total # MST (m) RFI (m)
van Sandick 2008 Netherlands 20 OS: 11 9 15 OS: 29 19 15
DFS: 8 DFS: 21
Tilleman 2009 USA 92 13.1 29 11 32
Lang-Lazdunski 2012 UK 54 23 22 12.8 33
Sugarbaker 2013 USA 72 35.3 27.1 31 228 12.8 16
Isik 2013 Turkey 19 15.4 13 6 34

DFS: disease free survival; HITHOC: hyperthermic intrathoracic chemotherapy; MST: median survival time; OSR: overall survival rate; RFI: recurrence free interval